Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry

Author:

Potpara Tatjana S12ORCID,Lip Gregory Y H34,Dagres Nikolaos5ORCID,Crijns Harry J M G67,Boriani Giuseppe8ORCID,Kirchhof Paulus91011ORCID,Arbelo Elena121314,Savelieva Irina15,Lenarczyk Radoslaw16ORCID,Fauchier Laurent17ORCID,Maggioni Aldo P1819,Gale Chris P20,

Affiliation:

1. School of Medicine, Belgrade University, Dr Subotica 8, 11000 Belgrade, Serbia

2. Cardiology Clinic, Clinical Centre of Serbia, Visegradska 26, 11000 Belgrade, Serbia

3. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK

4. Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark

5. Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany

6. Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands

7. Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands

8. University of Modena and Reggio Emilia, Modena, Italy

9. Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, Medical School, University of Birmingham, Edgbaston, Birmingham, UK

10. University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany

11. German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Barcelona, Spain

12. Department of Cardiology, Cardiovascular Institute, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain

13. Instit d’Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain

14. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain

15. Division of Cardiac and Vascular Sciences, Molecular and Clinical Sciences Research Institute, St George’s University of London, London, UK

16. Department of Cardiology, Congenital Heart Disease and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Silesian Medical University, 9 Curie-Sklodowskiej St., Zabrze, Poland

17. Service de Cardiologie, Centre Hospitalier Universitaire Trousseauet Faculté de Médecine EA7505, Université de Tours, Tours, France

18. EURObservational Research Programme, European Society of Cardiology, 2035 Route des Colles,Biot, 06903 Sophia-Antipolis, France

19. Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy

20. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK

Abstract

Abstract Aims The European Society of Cardiology (ESC) EURObservational Research Programme (EORP)-Atrial Fibrillation (AF) III Registry aims to identify contemporary patterns in AF management in clinical practice, assess their compliance with the 2016 ESC AF Guidelines, identify major gaps in guideline implementation, characterize the clinical practice settings associated with good vs. poor guideline implementation and assess and compare the 1-year outcome of guideline-adherent vs. guideline non-adherent management strategies. Methods and results Consecutive adult AF patients (n = 8306) were enrolled between 1 July 2018 and 15 July 2019, and individual patient data were prospectively collected across 192 centres and 31 participating countries during the 3-month enrolment period per centre. The Registry collected baseline and 1-year follow-up data in the eight main domains: patient demographic/enrolment setting, AF diagnosis/characterization, diagnostic assessment, stroke prevention treatments, arrhythmia-directed therapies, integrated AF management, major outcomes (death, non-fatal stroke or systemic embolic event, and non-fatal bleeding event), and the quality of life questionnaire. Conclusion The EORP-AF III Registry is an international, prospective registry of care and outcomes of patients treated for AF, which will provide insights into the contemporary patterns in AF management, ESC AF Guidelines implementation in routine practice and barriers to optimal management of this highly prevalent arrhythmia.

Funder

Abbott Vascular Int

Amgen Cardiovascular

AstraZeneca

Bayer AG

Boehringer Ingelheim

Boston Scientific

Bristol Myers Squibb

Pfizer Alliance

Daiichi Sankyo Europe GmbH

Alliance Daiichi Sankyo Europe GmbH

Eli Lilly and Company

Edwards

Gedeon Richter Plc

Menarini Int. Op

MSD-Merck & Co

Novartis Pharma AG

ResMed

Sanofi

Servier

Vifor

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3